How many acquisitions has Emmes made so far?

Emmes has completed 7 acquisitions so far.

Which countries does Emmes usually acquire in?

Emmes has made acquisitions in 5 countries with the most activity in United States and United Kingdom.

List of 7 Acquisitions by Emmes (Aug 2026)

Q: Which is Emmes' latest acquisition?

Emmes's most recent acquisition is VaxTrials, a CRO specializing in managing and monitoring vaccine clinical trials, acquired in October 2023.

Emmes has made a total of 7 acquisitions. These investments have been concentrated within 1 sector, Biopharma Outsourcing, across 5 countries, including United States, United Kingdom, and Germany. Peak activity occurred in 2021, 2022, and 2023, each with 2 acquisitions. The average number of acquisitions per year from 2020 to 2025 is 1.2, with 0 acquisitions completed this year. In October 2023, it acquired VaxTrials, a Panama-based CRO founded in 2012 that specializes in managing and monitoring vaccine clinical trials.

Here's the year on year acquisition history of Emmes:

Number of Total Acquisitions

Year	# Acquisitions
2023	2
2022	2
2021	2
2020	1

View all Acquisitions by Emmes

Recent acquisitions by Emmes

Emmes's most recent acquisition - VaxTrials is a CRO specializing in managing and monitoring vaccine clinical trials, founded in 2012 and located in Panama. Emmes acquired it in October 2023 for a price of $*****.

Here is the list of all acquisitions by Emmes sorted by the latest acquisition date:

Acquired on	Acquired Company	Acquisition Price	Facilitators	Stake Acquired	Acquisition Multiple
Oct 05, 2023	VaxTrials	azkk	eedc	19	955
Mar 21, 2023	Essex Management	agvj	vbrc	66	199
Sep 28, 2022	Clinical Edge	okqg	un{t	54	529
Mar 10, 2022	Casimir	rxub	{mlw	94	914
Dec 21, 2021	Institut Dr. Schauerte	grft	bokr	49	506

View the full list of acquisitions

View all Acquisitions by Emmes

Acquisitions by Emmes

List of Emmes's Acquisitions

Recent acquisitions by Emmes

FAQs about Acquisitions by Emmes